REPORT ID 1533

EMEA (Europe, Middle East and Africa) Intravenous Solutions Market Report 2017

Publish Date
06-Dec-17
Pages
122
Format
Electronic (PDF)

In this report, the EMEA Intravenous Solutions market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Intravenous Solutions for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Intravenous Solutions market competition by top manufacturers/players, with Intravenous Solutions sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Baxter
    Hospira
    B. Braun Melsungen
    Fresenius Kabi
    Claris Lifesciences
    Grifols
    Vifor Pharma
    JW Life Science
    Kelun Group
    CR Double-Crane
    SSY Group
    Cisen
    Tiandi
    Hualu
    Huaren
    Qidu
    Dubang
    Chimin
    BBCA
    Yaowang
    Tiancheng

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Crystalloids
    Colloids
    Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Intravenous Solutions for each application, including
    Basic IV Solutions
    Nutrient Infusion Solution
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Intravenous Solutions Market Report 2017
1 Intravenous Solutions Overview
    1.1 Product Overview and Scope of Intravenous Solutions
    1.2 Classification of Intravenous Solutions
        1.2.1 EMEA Intravenous Solutions Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Intravenous Solutions Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Crystalloids
        1.2.4 Colloids
        1.2.5 Other
    1.3 EMEA Intravenous Solutions Market by Application/End Users
        1.3.1 EMEA Intravenous Solutions Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Basic IV Solutions
        1.3.3 Nutrient Infusion Solution
        1.3.4 Other
    1.4 EMEA Intravenous Solutions Market by Region
        1.4.1 EMEA Intravenous Solutions Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Intravenous Solutions (2012-2022)
        1.5.1 EMEA Intravenous Solutions Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Intravenous Solutions Revenue and Growth Rate (2012-2022)

2 EMEA Intravenous Solutions Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Intravenous Solutions Market Competition by Players/Manufacturers
        2.1.1 EMEA Intravenous Solutions Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Intravenous Solutions Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Intravenous Solutions Sale Price by Players (2012-2017)
    2.2 EMEA Intravenous Solutions (Volume and Value) by Type/Product Category
        2.2.1 EMEA Intravenous Solutions Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Intravenous Solutions Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Intravenous Solutions Sale Price by Type (2012-2017)
    2.3 EMEA Intravenous Solutions (Volume) by Application
    2.4 EMEA Intravenous Solutions (Volume and Value) by Region
        2.4.1 EMEA Intravenous Solutions Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Intravenous Solutions Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Intravenous Solutions Sales Price by Region (2012-2017)

3 Europe Intravenous Solutions (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Intravenous Solutions Sales and Value (2012-2017)
        3.1.1 Europe Intravenous Solutions Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Intravenous Solutions Revenue and Growth Rate (2012-2017)
    3.2 Europe Intravenous Solutions Sales and Market Share by Type
    3.3 Europe Intravenous Solutions Sales and Market Share by Application
    3.4 Europe Intravenous Solutions Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Intravenous Solutions Sales Volume by Countries (2012-2017)
        3.4.2 Europe Intravenous Solutions Revenue by Countries (2012-2017)
        3.4.3 Germany Intravenous Solutions Sales and Growth Rate (2012-2017)
        3.4.4 France Intravenous Solutions Sales and Growth Rate (2012-2017)
        3.4.5 UK Intravenous Solutions Sales and Growth Rate (2012-2017)
        3.4.6 Russia Intravenous Solutions Sales and Growth Rate (2012-2017)
        3.4.7 Italy Intravenous Solutions Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Intravenous Solutions Sales and Growth Rate (2012-2017)

4 Middle East Intravenous Solutions (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Intravenous Solutions Sales and Value (2012-2017)
        4.1.1 Middle East Intravenous Solutions Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Intravenous Solutions Revenue and Growth Rate (2012-2017)
    4.2 Middle East Intravenous Solutions Sales and Market Share by Type
    4.3 Middle East Intravenous Solutions Sales and Market Share by Application
    4.4 Middle East Intravenous Solutions Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Intravenous Solutions Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Intravenous Solutions Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Intravenous Solutions Sales and Growth Rate (2012-2017)
        4.4.4 Israel Intravenous Solutions Sales and Growth Rate (2012-2017)
        4.4.5 UAE Intravenous Solutions Sales and Growth Rate (2012-2017)
        4.4.6 Iran Intravenous Solutions Sales and Growth Rate (2012-2017)

5 Africa Intravenous Solutions (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Intravenous Solutions Sales and Value (2012-2017)
        5.1.1 Africa Intravenous Solutions Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Intravenous Solutions Revenue and Growth Rate (2012-2017)
    5.2 Africa Intravenous Solutions Sales and Market Share by Type
    5.3 Africa Intravenous Solutions Sales and Market Share by Application
    5.4 Africa Intravenous Solutions Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Intravenous Solutions Sales Volume by Countries (2012-2017)
        5.4.2 Africa Intravenous Solutions Revenue by Countries (2012-2017)
        5.4.3 South Africa Intravenous Solutions Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Intravenous Solutions Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Intravenous Solutions Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Intravenous Solutions Sales and Growth Rate (2012-2017)

6 EMEA Intravenous Solutions Manufacturers/Players Profiles and Sales Data
    6.1 Baxter
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Intravenous Solutions Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Baxter Intravenous Solutions Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Hospira
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Intravenous Solutions Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Hospira Intravenous Solutions Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 B. Braun Melsungen
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Intravenous Solutions Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 B. Braun Melsungen Intravenous Solutions Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Fresenius Kabi
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Intravenous Solutions Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Fresenius Kabi Intravenous Solutions Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Claris Lifesciences
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Intravenous Solutions Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Claris Lifesciences Intravenous Solutions Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Grifols
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Intravenous Solutions Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Grifols Intravenous Solutions Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Vifor Pharma
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Intravenous Solutions Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Vifor Pharma Intravenous Solutions Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 JW Life Science
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Intravenous Solutions Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 JW Life Science Intravenous Solutions Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Kelun Group
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Intravenous Solutions Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Kelun Group Intravenous Solutions Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 CR Double-Crane
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Intravenous Solutions Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 CR Double-Crane Intravenous Solutions Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 SSY Group
    6.12 Cisen
    6.13 Tiandi
    6.14 Hualu
    6.15 Huaren
    6.16 Qidu
    6.17 Dubang
    6.18 Chimin
    6.19 BBCA
    6.20 Yaowang
    6.21 Tiancheng

7 Intravenous Solutions Manufacturing Cost Analysis
    7.1 Intravenous Solutions Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Intravenous Solutions

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Intravenous Solutions Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Intravenous Solutions Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Intravenous Solutions Market Forecast (2017-2022)
    11.1 EMEA Intravenous Solutions Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Intravenous Solutions Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Intravenous Solutions Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Intravenous Solutions Price and Trend Forecast (2017-2022)
    11.2 EMEA Intravenous Solutions Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Intravenous Solutions Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Intravenous Solutions Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Intravenous Solutions Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Intravenous Solutions Sales Forecast by Type (2017-2022)
    11.7 EMEA Intravenous Solutions Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer